Personnel

Levin named to scientific advisory board at infectious disease firm

Published in Hepatitis Weekly, October 6th, 2003

Aethlon Medical, Inc., (AEMD) announced that Nathan W. Levin, MD, has been appointed to the company's science advisory board.

Levin is the medical and research director of the Renal Research Institute LLC, a joint venture between Fresenius Medical Care - North America and Beth Israel Medical Center, New York.

Levin also serves as professor of clinical medicine at the Albert Einstein College of Medicine.

Aethlon Medical is developing therapeutic devices that treat HIV/AIDS, hepatitis-C, and other infectious diseases. In preclinical testing, Aethlon's lead product, AEMD-45 removed 55% of HIV from human blood in 3 hours and in excess...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2003-10-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry